Product information and disease descriptionPlace of product in therapyApproaches to treatment
Heterogeneity of treatment effect
12 evidence topics · 11 sources
Baseline severity and antidepressant efficacy in GAD: individual participant data
“For GAD and PD, severity moderated antidepressant efficacy. The antidepressant–placebo difference was 1.4 (95% CI: 0.4–2.5; SMD: 0.21) Hamilton Anxiety Rating Scale (HAM‐A) points for participants with mild GAD (baseline HAM‐A = 10), increasing to 4.0 (3.4–4.6; SMD: 0.45) or greater for severely ill participants (HAM‐A ≥ 30).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Half of the GAD trials specified a minimum HAM‐A score of 20, for instance, even though most primary care patients with GAD have scores below 20 (Rollman et al., 2005).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Age as a moderator of psychotherapy and medication effects
“Mean age of the sample was a significant moderator of psychotherapy outcomes. A lower mean age predicted a larger treatment effect size in psychotherapy (β = −0.013, p < 0.05).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Mean age was not associated with outcome in medication studies (p > 0.05).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“There was no significant relationship between effect size and treatment dose (number of sessions or medication dosage), treatment quality, year of publication, fixed versus flexible dose, percent comorbidity, percent female, or pretreatment severity (all p > 0.10).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Older adults
“Twenty-seven trials (14 pharmacological, 13 psychotherapeutic) fulfilled the inclusion criteria, reporting results from 2373 baseline participants.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Pooled treatment effects for pharmacological (OR=0.32, 95% CI: 0.18, 0.54) and psychotherapeutic (OR=0.33, 95% CI: 0.17, 0.66) trials were similar, with findings in each case favoring active interventions over control conditions.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
DT120 in Voyage: change in HAM-A score at Week 12 by subgroup
| Subgroup | Placebo-adjusted LS mean change (SE) |
|---|---|
| All participants | “−5.4 (1.0)” |
| Time since GAD symptoms began, less than 22 years (n = 107) | “−5.9 (1.4)” |
| Time since GAD symptoms began, 22 years or more (n = 107) | “−4.7 (1.5)” |
| Previous GAD medications, fewer than 2 (n = 136) | “−4.2 (1.2)” |
| Previous GAD medications, 2 or more (n = 78) | “−5.6 (1.7)” |
| Male (n = 77) | “−7.1 (1.7)” |
| Female (n = 137) | “−5.5 (1.2)” |
DT120 in Panorama: subgroups and stability of subgroup estimates
Functional unblinding and dose in the phase 2b trial
“All doses of MM120 produced transient perceptual, cognitive, and emotional effects leading to participant unblinding.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Central rater blinding was preserved in more than 80% of HAM-A assessments,31 despite approximately 85% of participants correctly identifying assignment to active treatment.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Expectancy and blinding in psychedelic trials
“While psychedelic RCTs have generally shown promising results, with large effect sizes reported, we argue that treatment effect sizes in psychedelic RCTs are likely over-estimated due to de-blinding of participants and high levels of response expectancy.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“We suggest that psychedelic RCTs should routinely measure de-blinding and expectancy.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote